Ep. 179 "Uncover What Real-World Data Means for Moderate-to-Severe Psoriasis Patients" A Sun Pharma sponsored episode.
Nov 03, 2022•25 min•Ep. 179
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Treatment options backed by real-world evidence means more opportunities for those living with moderate-to-severe plaque psoriasis. Join Steve Rozzo, Ph.D., Sun Pharma, and Neal Bhatia, M.D., Therapeutics Clinical Research in San Diego, CA in a Q&A discussion on real-world clinical data of ILUMYA® and what the findings mean for moderate-to-severe plaque psoriasis patients. Episode sponsored by Sun Pharma. Important safety information: https://bit.ly/2We7fIS .
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast